Erythrocyte Arginase Activity As an Indicator of Lead Exposure

Overview

Journal Br J Ind Med

Specialty Occupational Medicine

Date 1983 Feb 1

PMID 6824592

Citations 3

Authors

K Fukumoto

I Karai

Y Nishikawa

S Horiguchi

Affiliations

Soon will be listed here.

Citing Articles

Interplay Between Metabolic Pathways and Increased Oxidative Stress in Human Red Blood Cells.

Spinelli S, Marino A, Morabito R, Remigante A Cells. 2024; 13(23).

PMID: 39682773 PMC: 11640724. DOI: 10.3390/cells13232026.

L-Arginine-Dependent Nitric Oxide Production in the Blood of Patients with Type 2 Diabetes: A Pilot, Five-Year Prospective Study.

Stoian I, Iosif L, Gilca M, Vlad A, Tivig I, Bradescu O Life (Basel). 2024; 14(5).

PMID: 38792578 PMC: 11122261. DOI: 10.3390/life14050556.

Erythrocyte arginase, pyrimidine 5'-nucleotidase (P5N), and deoxypyrimidine 5'-nucleotidase (dP5N) as indices of lead exposure.

COOK L, ANGLE C, Stohs S Br J Ind Med. 1986; 43(6):387-90.

PMID: 3013277 PMC: 1007668. DOI: 10.1136/oem.43.6.387.

References

Tomokuni K, Ogata M . Simple method for determination of urinary -aminolevulinic acid as an index of lead exposure. Clin Chem. 1972; 18(12):1534-8. View

Nishibe H, Yamagata K, Goto H . A case of sideroblastic anaemia associated with marked elevation of erythrocytic arginase activity. Scand J Haematol. 1975; 15(1):17-21. DOI: 10.1111/j.1600-0609.1975.tb01050.x. View

ROHOLT Jr O, Greenberg D . Liver arginase. IV. Effect of pH on kinetics of manganese-activated enzyme. Arch Biochem Biophys. 1956; 62(2):454-70. DOI: 10.1016/0003-9861(56)90144-8. View

BREMNER I, Young B, Mills C . Protective effect of zinc supplementation against copper toxicosis in sheep. Br J Nutr. 1976; 36(3):551-61. DOI: 10.1079/bjn19760108. View

PELIKAN V, Kalab M, Tichy J . DETERMINATION OF ARGINASE ACTIVITY IN BLOOD IN EPIDEMIC HEPATITIS. Clin Chim Acta. 1964; 9:141-7. DOI: 10.1016/0009-8981(64)90007-5. View

FORSELL O, Palva I . Determination of arginase in serum. Scand J Clin Lab Invest. 1961; 13:131-3. DOI: 10.3109/00365516109137261. View

Karai I, Fukumoto K, Horiguchi S . Improvement in the atomic absorption determination of lead in blood. J Appl Toxicol. 1981; 1(6):295-6. DOI: 10.1002/jat.2550010604. View

KEHOE R . Standards for the prevention of occupational lead poisoning. Arch Environ Health. 1971; 23(4):245-8. DOI: 10.1080/00039896.1971.10665995. View

Chmielnicka J, Komsta-Szumska E, Szymanska J . Arginase and kallikrein activities as biochemical indices of occupational exposure to lead. Br J Ind Med. 1981; 38(2):175-8. PMC: 1008842. DOI: 10.1136/oem.38.2.175. View

10.

Reynolds J, FOLLETTE J, Valentine W . The arginase activity of erythrocytes and leukocytes with particular reference to pernicious anemia and thalassemia major. J Lab Clin Med. 1957; 50(1):78-92. View

11.

Yamada Y, Kido T, Okada A, Nogawa K, Kobayashi E . [Studies on the biological effects of low level lead exposures. Part 1. Estimation of usefulness of some biochemical tests as parameters for occupational lead exposures (author's transl)]. Sangyo Igaku. 1981; 23(3):260-9. DOI: 10.1539/joh1959.23.260. View

12.

Sano S, Granick S . Mitochondrial coproporphyrinogen oxidase and protoporphyrin formation. J Biol Chem. 1961; 236:1173-80. View

13.

Cederbaum S, SHAW K, Valente M . Hyperargininemia. J Pediatr. 1977; 90(4):569-73. DOI: 10.1016/s0022-3476(77)80368-5. View

14.

TERHEGGEN H, LOWENTHAL A, Lavinha F, COLOMBO J . Familial hyperargininaemia. Arch Dis Child. 1975; 50(1):57-62. PMC: 1544492. DOI: 10.1136/adc.50.1.57. View

15.

Ugarte G, PINO M, Peirano P, MARUSIC E . Serum arginase activity in subjects with hepatocellular damage. J Lab Clin Med. 1960; 55:522-9. View